Efficacy of Low-Dose Radioiodine Ablation in Low- and Intermediate-Risk Differentiated Thyroid Cancer: A Retrospective Comparative Analysis

Efficacy of Low-Dose Radioiodine Ablation in Low- and Intermediate-Risk Differentiated Thyroid Cancer: A Retrospective Comparative Analysis

(1) Background—low-dose radioiodine ablation is an accepted strategy for the treatment of low- and intermediate-risk thyroid carcinomas, although there is no international consensus. The aim of this study is to describe the clinical experience with low-dose radioiodine ablation in patients...

Full description

Bibliographic Details
Main Authors: Ana María Gómez-Pérez, Jorge García-Alemán, María Molina-Vega, Arantzazu Sebastián Ochoa, Pilar Pérez García, Isabel Mancha Doblas, Francisco J Tinahones
Format: Article
Language:English
Published: MDPI AG 2020-02-01
Series:Journal of Clinical Medicine
Subjects:
differentiated thyroid cancer
radioiodine
low-dose ablation
low-risk
antithyroglobulin antibodies
Online Access:https://www.mdpi.com/2077-0383/9/2/581

Internet

https://www.mdpi.com/2077-0383/9/2/581

Similar Items